Xcout Intel
BioAgilytix
BioAgilytix is a global leader in bioanalytical services with advanced laboratory facilities located in Durham, North Carolina, alongside European and Australian headquarters to support pharmaceutical and biotech development.
Subscribe to see BioAgilytix’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BioAgilytix at a glance
BioAgilytix is a biotech company. Xcout tracks 23 named people at BioAgilytix, including Davide Molho (Chief Executive Officer (CEO)). Xcout recorded 37 job postings from BioAgilytix in the last 90 days.
BioAgilytix leadership
- Davide MolhoChief Executive Officer (CEO)
- Alistair DraffanPresident, 360biolabs, Australia Lab
- Linda RobbieChief Operating Officer
- Maureen MarchekChief Financial Officer
- Ed AmatChief Growth Officer
- Mehul PatelChief Information Officer
17 more named people on record for BioAgilytix, with roles, board committees and tenure — see the full roster →
Hiring at BioAgilytix
Xcout recorded 37 job postings from BioAgilytix in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see BioAgilytix's hiring signals →
BioAgilytix competitors
A few of BioAgilytix's closest competitors — see the full list of competitors and alternatives →
Agilex Biolabs is an Australian contract research organization (CRO) providing bioanalytical services, toxicology, and clinical trial support for pharmaceutical and biotechnology companies.
Novotech is a global full-service clinical research organization (CRO) founded in Australia and headquartered in Singapore that drives innovation in drug development.
Meadowhawk Biolabs, Inc. is a preclinical contract research organization that provides expert bioanalysis and related research services.
Celerion operates as an early-phase clinical research contract research organization (CRO) providing bioanalytical sciences, drug development, and regulatory services to pharmaceutical and biotechnology companies. The company conducts early-phase clinical trials, pharmacokinetic and pharmacodynamic analysis, immunogenicity testing, and biomarker analysis to accelerate drug development processes.
WuXi Biology provides a comprehensive spectrum of preclinical biology services and solutions for drug discovery, supporting clients from target discovery and validation to hit finding, lead optimization, and candidate selection. The company offers specialized platforms and expertise across major disease areas and therapeutic modalities, including small molecules, oligonucleotides, peptides, and antibodies.
Worldwide Clinical Trials is a global contract research organization that provides drug development and clinical trial services to pharmaceutical and biotechnology companies. The company offers end-to-end solutions, including early and late phase clinical trials, bioanalytical laboratory services, data management, and consulting across various therapeutic areas such as oncology, neuroscience, and rare diseases.
Get BioAgilytix's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on BioAgilytix in Xcout Intel
- 23 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access